Check-Cap Ltd. Ordinary Share
Check-Cap Ltd. Ordinary Share
Your view on MBAI
Overview
What the company does, where it operates, and who runs it.
About Check-Cap Ltd. Ordinary Share
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- David Lontini
- Headquarters
- IL
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- David Lontini
- Headquarters
- IL
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Check-Cap Ltd. Ordinary Share, and the rating behind it. MBAI last traded at $6.40, 1.4× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Check-Cap Ltd. Ordinary Share. Starting points for Check-Cap Ltd. Ordinary Share: P/E 1.4, EPS $4.65, beta 0.82 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Check-Cap Ltd. Ordinary Share. Check-Cap Ltd. Ordinary Share does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Check-Cap Ltd. Ordinary Share. Trailing twelve-month EPS for Check-Cap Ltd. Ordinary Share stands at $4.65. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Check-Cap Ltd. Ordinary Share. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Check-Cap Ltd. Ordinary Share valued side by side against its closest peers. Check-Cap Ltd. Ordinary Share is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Check-Cap Ltd. Ordinary Share, and how their positions are changing. At a $6.4M market value, institutional positions materially move Check-Cap Ltd. Ordinary Share's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Check-Cap Ltd. Ordinary Share executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Check-Cap Ltd. Ordinary Share. Check-Cap Ltd. Ordinary Share is a $6.4M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Check-Cap Ltd. Ordinary Share. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Check-Cap Ltd. Ordinary Share. Coverage tracks Check-Cap Ltd. Ordinary Share within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.